← Browse by Condition
Medical Condition
cns tumors
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 4
NCT06441331 Phase 1
Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Enrollment
20 pts
Location
United States, Spain
Sponsor
ITM Solucin GmbH
NCT04081701 Phase 4
Recruiting
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Enrollment
200 pts
Location
United States
Sponsor
Weill Medical College of Corne...